1765 Aufrufe 1765 0 Kommentare 0 Kommentare

    Onco-Innovations Announces Private Placement

    Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / October 14, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the …

    Not for distribution to United States wire services or for dissemination in the United States

    VANCOUVER, BC / ACCESS Newswire / October 14, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") announces that it intends to complete a non-brokered private placement (the "Private Placement") of up to 1,428,572 units of the Company (the "Units") at a price of $1.40 per Unit, for aggregate gross proceeds of up to $2,000,000. Each Unit shall consist of one common share (each a "Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant"), with each Warrant entitling the holder to purchase one Share at an exercise price of $2.00 for a period of thirty-six (36) months.

    The Company also intends to issue Shares equal to 1.0% of the total of Shares issued in the Private Placement (the "Admin Fee Shares") to an arm's-length third party, as an administrative fee for their assistance with the Private Placement.

    In connection with the Private Placement, the Company may pay finders' fees and/or issue finders' warrants on the same terms as the Warrants, to eligible parties who have assisted by introducing subscribers to the Private Placement.

    Closing of the Private Placement is subject to certain conditions, including, but not limited to, the receipt of all necessary regulatory and other approvals. All securities issued pursuant to Private Placement will be subject to a hold period of four months and one day pursuant to applicable securities laws. The Company intends to use the proceeds of the Private Placement for general corporate and working capital purposes, including in pursuit of the Company's operational and research and development objectives and for investor relations purposes.

    The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any U.S. state securities laws, and may not be offered or sold in the United States absent registration or available exemptions from such registration requirements. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States, or in any jurisdiction in which such offer, solicitation or sale would be unlawful.

    Seite 1 von 3 




    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We are ACCESS Newswire, a globally trusted Public Relations (PR) and Investor Relations (IR) solutions provider. With a focus on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands to connect with their audiences where it matters most. From startups and scale-ups to multi-billion-dollar global brands, we ensure your most important moments make an impact and resonate with your audiences.
    Mehr anzeigen

    Verfasst von Accesswire
    Onco-Innovations Announces Private Placement Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / October 14, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the …